Literature DB >> 29712860

The C-terminal extension landscape of naturally presented HLA-I ligands.

Philippe Guillaume1, Sarah Picaud2,3, Petra Baumgaertner1, Nicole Montandon1, Julien Schmidt1, Daniel E Speiser1, George Coukos1, Michal Bassani-Sternberg1, Panagis Filippakopoulos2,3, David Gfeller4,5.   

Abstract

HLA-I molecules play a central role in antigen presentation. They typically bind 9- to 12-mer peptides, and their canonical binding mode involves anchor residues at the second and last positions of their ligands. To investigate potential noncanonical binding modes, we collected in-depth and accurate HLA peptidomics datasets covering 54 HLA-I alleles and developed algorithms to analyze these data. Our results reveal frequent (442 unique peptides) and statistically significant C-terminal extensions for at least eight alleles, including the common HLA-A03:01, HLA-A31:01, and HLA-A68:01. High resolution crystal structure of HLA-A68:01 with such a ligand uncovers structural changes taking place to accommodate C-terminal extensions and helps unraveling sequence and structural properties predictive of the presence of these extensions. Scanning viral proteomes with the C-terminal extension motifs identifies many putative epitopes and we demonstrate direct recognition by human CD8+ T cells of a 10-mer epitope from cytomegalovirus predicted to follow the C-terminal extension binding mode.

Entities:  

Keywords:  HLA peptidomics; HLA-I structures; HLA-I–peptide interactions; T cell epitope; computational immunology

Mesh:

Substances:

Year:  2018        PMID: 29712860      PMCID: PMC5960288          DOI: 10.1073/pnas.1717277115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanism.

Authors:  A Stryhn; L O Pedersen; A Holm; S Buus
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

2.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.

Authors:  H C Guo; T S Jardetzky; T P Garrett; W S Lane; J L Strominger; D C Wiley
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

3.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.

Authors:  Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; Søren Buus; Hansjörg Schild; Peter van Endert; Astrid K N Iversen
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

4.  Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Authors:  Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

5.  Crystal structure of a TAPBPR-MHC I complex reveals the mechanism of peptide editing in antigen presentation.

Authors:  Jiansheng Jiang; Kannan Natarajan; Lisa F Boyd; Giora I Morozov; Michael G Mage; David H Margulies
Journal:  Science       Date:  2017-10-12       Impact factor: 47.728

6.  Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B.

Authors:  Julian P Vivian; Renee C Duncan; Richard Berry; Geraldine M O'Connor; Hugh H Reid; Travis Beddoe; Stephanie Gras; Philippa M Saunders; Maya A Olshina; Jacqueline M L Widjaja; Christopher M Harpur; Jie Lin; Sebastien M Maloveste; David A Price; Bernard A P Lafont; Daniel W McVicar; Craig S Clements; Andrew G Brooks; Jamie Rossjohn
Journal:  Nature       Date:  2011-10-23       Impact factor: 49.962

7.  Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.

Authors:  Michal Bassani-Sternberg; Eva Bräunlein; Richard Klar; Thomas Engleitner; Pavel Sinitcyn; Stefan Audehm; Melanie Straub; Julia Weber; Julia Slotta-Huspenina; Katja Specht; Marc E Martignoni; Angelika Werner; Rüdiger Hein; Dirk H Busch; Christian Peschel; Roland Rad; Jürgen Cox; Matthias Mann; Angela M Krackhardt
Journal:  Nat Commun       Date:  2016-11-21       Impact factor: 14.919

8.  GibbsCluster: unsupervised clustering and alignment of peptide sequences.

Authors:  Massimo Andreatta; Bruno Alvarez; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

9.  High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.

Authors:  Danilo Ritz; Andreas Gloger; Benjamin Weide; Claus Garbe; Dario Neri; Tim Fugmann
Journal:  Proteomics       Date:  2016-05       Impact factor: 3.984

10.  The immune epitope database (IEDB) 3.0.

Authors:  Randi Vita; James A Overton; Jason A Greenbaum; Julia Ponomarenko; Jason D Clark; Jason R Cantrell; Daniel K Wheeler; Joseph L Gabbard; Deborah Hix; Alessandro Sette; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

View more
  15 in total

Review 1.  Antitumour dendritic cell vaccination in a priming and boosting approach.

Authors:  Alexandre Harari; Michele Graciotti; Michal Bassani-Sternberg; Lana E Kandalaft
Journal:  Nat Rev Drug Discov       Date:  2020-08-06       Impact factor: 84.694

2.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

Review 3.  Structural Prediction of Peptide-MHC Binding Modes.

Authors:  Marta A S Perez; Michel A Cuendet; Ute F Röhrig; Olivier Michielin; Vincent Zoete
Journal:  Methods Mol Biol       Date:  2022

4.  Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.

Authors:  Thomas Partridge; Annalisa Nicastri; Anna E Kliszczak; Louis-Marie Yindom; Benedikt M Kessler; Nicola Ternette; Persephone Borrow
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

Review 5.  Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy.

Authors:  Jan A Rath; Caroline Arber
Journal:  Cells       Date:  2020-06-18       Impact factor: 6.600

Review 6.  Predicting Antigen Presentation-What Could We Learn From a Million Peptides?

Authors:  David Gfeller; Michal Bassani-Sternberg
Journal:  Front Immunol       Date:  2018-07-25       Impact factor: 7.561

7.  Challenging immunodominance of influenza-specific CD8+ T cell responses restricted by the risk-associated HLA-A*68:01 allomorph.

Authors:  C E van de Sandt; E B Clemens; E J Grant; L C Rowntree; S Sant; H Halim; J Crowe; A C Cheng; T C Kotsimbos; M Richards; A Miller; S Y C Tong; J Rossjohn; T H O Nguyen; S Gras; W Chen; K Kedzierska
Journal:  Nat Commun       Date:  2019-12-06       Impact factor: 14.919

8.  ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.

Authors:  Lenong Li; Mansoor Batliwala; Marlene Bouvier
Journal:  J Biol Chem       Date:  2019-10-10       Impact factor: 5.157

9.  Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First.

Authors:  Yanan Wu; Nianzhi Zhang; Keiichiro Hashimoto; Chun Xia; Johannes M Dijkstra
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

10.  Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands.

Authors:  Marta A S Perez; Michal Bassani-Sternberg; George Coukos; David Gfeller; Vincent Zoete
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.